Sinovac Names Danny Chung Chief Financial Officer
Sinovac Biotech Ltd. (Nasdaq: SVA) has appointed Mr. Danny Chung as Chief Financial Officer, effective immediately. Ms. Nan Wang, who has served as interim Chief Financial Officer since August 2011, will continue as the Company's Vice President.
"Mr. Chung possesses the relevant experiences and credentials, which meet the Company's needs," said Dr. Weidong Yin, Chairman and CEO. "Beyond his audit and accounting expertise, Mr. Chung has proven adept in the financial management of Chinese divisions of multinational companies. We are pleased to welcome him to Sinovac."
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.